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of patients in each glucose range were as follows: 80-120mg/dl (38.6%),
120-160mg/dl (37.8%), 160-200mg/dl (13.9%), 200mg/dl
(9.7%). Univariate analysis of the data revealed that hyperglycemia
greater than 120mg/dl was associated with increased risk of MI, CVA,
respiratory complication, and the likelihood of having two or more
complications. Multivariate analysis confirmed that serum glucose
greater than 120mg/dl was associated with an increase in OR for MI
2.01 (1.23-3.27), CVA 2.20 (1.48-3.29), respiratory complication 1.81
(1.28-2.54), and incidence of two or more complications 1.82 (1.05-
3.14). Also, odds ratio of complications increased with each increase in
glucose range, as shown in Table 1.
Conlusion: Postoperative hyperglycemia above 120mg/dl is associ-
ated with an increased risk of complications following CEA. The magnitude
of increased risk is directly proportional to the level of hyperglycemia,
indicating that hyperglycemia-associated morbidity may be mitigated even if
glucose cannot be strictly controlled to normoglycemic levels.
Table 1. Adjusted odds ratio of complications by glucose
range
Glucose
MI CVA Respiratory
 2
Complications
OR
(95% CI)
OR
(95% CI)
OR
(95% CI)
OR
(95% CI)
120-160 2.01** (1.23-3.27) 2.20*** (1.48-3.29) 1.81** (1.28-2.54) 1.82* (1.05-3.14)
160-200 2.84*** (1.61-4.99) 4.63*** (2.88-7.44) 3.13*** (2.06-4.75) 4.67*** (2.53-8.64)
200 3.94*** (2.24-6.93) 5.44*** (3.17-9.35) 4.51*** (2.85-7.12) 6.17*** (3.09-12.31)
1. 80-120 is the reference glucose range for all comparisons.
*p.05.
**p.01.
***p.001.
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RR4.
Clinical Course of Asymptomatic Patients with Carotid Duplex Scan
End-Diastolic Velocities of 100 - 124 cm/second
Thomas S. Riles, Caron Rockman, Thomas S. Maldonado, Victoria Lee,
David Cheever, Firas F Mussa, Glenn R. Jacobowitz. New York University
Medical Center, New York, NY
Background:With the decline of diagnostic angiography, clinicians often
rely upon Duplex criteria to select asymptomatic patients for carotid interven-
tion. Recent trials have enrolled patients based upon end diastolic velocities
(EDV) as low as 100 cm/sec, and peak systolic velocities (PSV) as low as 230
cm/sec. In as much as we have used more stringent criteria, we reviewed the
course of asymptomatic patients with EDV’s from 100-124 cm/sec.
Methods: Of patients scanned in our ICAVL accredited laboratory
from 2002-2007, 143 had an EDV 100-124 cm/sec. Some underwent
initial carotid intervention for concomitant symptoms (10), contralateral
occlusion (3), or other imaging findings felt to warrant intervention (34).
The remaining 96 patients (97 arteries) were followed. Mean follow-up was
31.4 months (range 2-137).
Results: Six patients (6.3%) developed ipsilateral symptoms consisting
of 3 strokes and 3 TIA’s, at a mean of 29.6 months (range 6-58). Twenty
patients (20.8%), including two that developed symptoms, progressed to an
EDV of125 cm/sec at a mean of 23months (range 4-127). Three of these
(3.1%) progressed directly to occlusion with no documented interim wors-
ening of stenosis. Survival analysis revealed that freedom from TIA or stroke
was 98.7%, 97.1% and 94.7%, while freedom from stenosis progression was
89.5%, 74.2%, and 74.2% at 12, 24, and 36months respectively. A total of 32
patients (33.3%) eventually underwent carotid intervention for the onset of
symptoms (n7, 7.3%), progression to 125 EDV (n14, 14.6%), or for
other imaging findings (n11, 11.5%). The mean interval to intervention
was 23.9 months (range 3-137).
Conclusions: For asymptomatic patients with an EDV of 100-124
cm/sec, the risk of ipsilateral stroke is small and conservative management is
appropriate in most cases. However, the risk of progression to a more severe
degree of stenosis, often warranting carotid intervention within 2 years, is
clinically meaningful. Yearly Duplex follow-up is necessary to assess disease
progression in this cohort.12
Months
24
Months
36
Months
Freedom from ipsilateral stroke 100% 100% 97.1%
Freedom from TIA or stroke 98.7% 97.1% 94.7%
Freedom from progression to
EDV  125 cm/sec
89.5% 74.2% 74.2%
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Carotid Higlhly-calcified “De Novo” Stenosis and Cutting-balloon
Angioplasty: A Tool to Prevent Haemodynamic Depression?
Setacci Carlo, Setacci Francesco, Sirignano Pasqualino, Chisci Emiliano,
GalzeranoGiuseppe, deDonato Gianmarco. University of Siena, Siena, Italy
Background: Severe highly-calcified “de-novo” lesions of carotid ar-
teries are important predictors of haemodynamic depression (HD) after
carotid artery stenting (CAS). Cutting-balloon angioplasty (CBA) using
low-inflation pressures has been described as an effective method to achieve
important luminal gain and avoid HD.
Methods: From January 2005 to December 2007 one hundred and
two consecutive patients (mean age 76.367.54 years) with severe highly-
calcified “de novo” lesions of carotid artery undergoing CAS were prospec-
tively observed and randomized in two groups: group 1 (n50) underwent
standard CAS, group 2 (n52) underwent CAS with CBA. Patients with
prior ipsilateral carotid endarterectomy (CEA), beta-blockers therapy or
arrhytmias were excluded. HD was defined as periprocedural hypotension
(systolic blood pressure 90mmHg) or bradycardia (heart rate 60beats/
min). CBA angioplasty was carried-out using CB coronary device, 0.014
inch compatible, from 3 to 4 mm or CB peripheral device, 0.018 inch
compatible, from 5 to 6 mm in diameter, inflated at a mean-maximum value
of 8.6 atmospheres; the average number of cuts per lesion was 2.7.
Results: Demographic and clinical characteristic of both groups at the
basal conditions were comparable. HDoccurred in 18/50 (36%) procedures
in Group 1, while in 3/52 (5.76%) in Group 2. The difference between the
two groups concerning HD incidence was statistically significant
(p0.001). There was a strong (p0.001) association between HD and
CBA and the OR0.109 (95%CI 0.019-0.425) confirmed the protective
role of CBA. No major intraprocedural complications were observed in this
series. Post-procedural Doppler Ultrasound scan showed one case (2%) of
in-stent “restenosis” in Group 1 representing early failure due to recoil, and
only one (1.92%) neurological adverse event (TIA) in group 2.
Conclusions: Following the experience in coronary and other districts
and in carotid ISR36, we extended the potential benefits of the CB technique
applying CBA to severe highly-calcified “de novo” lesions of carotid arteries.
HD is a common occurrence after CAS, especially in patients with both long
and calcified plaque. Only a tailored procedure with a correct remodelling of
the plaque allows to avoid both HD and elastic recoil of the target lesion.
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Long-term Outcomes and Predictors of Microemboli following Ca-
rotid Interventions
Wei Zhou, Rosa Zareie, David Dinishak, Maureen Tedesco, Barton Lane,
Fritz Bech, Ronald Dalman, Allyson Rosen. Stanford University, Stanford, CA
Objectives: Significant numbers of microemboli on diffusion-weighted
magnetic resonance imaging (DWI)have been identified immediately following
carotid stenting procedures (CAS), but the clinical significance of these micro-
emboli is largely unknown. This study was to evaluate long-term outcomes and
risk factors predictive of microemboli following CAS.
Methods: Patients who underwent perioperative MRI evaluations for
carotid interventions at a single institution from 7/2004 to 12/2008 were
evaluated, particularly those who had additional follow-up MRI. DWI with
apparent diffusion coefficient (ADC), FLAIR, and T2W MRI images were
compared to determine long-term effect of microemboli. Risk factors in-
cluding patient demographic, clinical symptoms, lesion characteristics, and
perioperative hemodynamic status were analyzed using a Cox regression
model, in a stepwise procedure.Results: One-hundred sixty-eight consecutive patients (68 CAS and
100 CEA) who received perioperative MRI were included. The incidence of
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and 12% respectively, P0.05) despite a relative low incidence of associated
neurologic symptoms (2.6 % vs. 2%). Thirty patients (16 CAS and 14 CEA)
with 50 DWI lesions (mean size 46.57mm2, ranging 16 to 128mm2) were
further analyzed. During a mean MRI follow-up of 10 months (range, 2 to
23months), residual MRI abnormalities were only identified in DWI lesions
larger than 60mm2 (n5, P0.001). CEA group had fewer but larger
ipsilaterally distributed emboli (total 12 lesions, mean 79mm2) comparing
to CAS group (total 38 lesions, mean 27.5mm2, P0.05). Regression
analyses of 68 CAS patients (mean age 71 years, range, 53-91 years) showed
that date of procedure prior to 1/2007, coronary artery disease, diabetes,
and perioperative troponin elevation were significant predictors of micro-
emboli (P0.03). Date of procedure was the only predictor of bilateral
hemispheres microemboli (p0.025).
Conclusions: Carotid interventions are associated with significant
DWI lesions despite absence of clinical symptoms. Risks of microemboli
correlate to physician experience and patient selection. Larger DWI lesions
(60mm2) can lead to long-term residual structure abnormalities that
warrants further neurocognitive evaluation.
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Treatment Strategies of Arterial Steal After Arterio-Venous (AV)
Access
Navyash Gupta, Theodore H Yuo, Gerhardt Konig, Ellen D Dillavou,
Steven A Leers, Rabih A Chaer, Jae S Cho, Michel S Makaroun. University
of Pittsburgh, Pittsburgh, PA
Objectives: Ischemic steal (IS) associated with an AV access is rare, but
can result in severe complications. Multiple techniques have been described
to treat IS with varying degrees of success. This study compares these
options.
Methods: Patients with IS from June 2003 to August 2008 were
reviewed. Demographics, type of AV access, management technique and
success of intervention were recorded. Success was defined as resolution of
IS symptoms while preserving access function. Further, 100 consecutive AV
access procedures were reviewed for current practice patterns. We analyzed
data using z- and chi-squared tests. The study was approved by our IRB.
Results: A total of 114 patients with IS had a mean age of 65 years
(range 20-90) and were predominantly female (66%), diabetic (61%), and
had proximal brachio-cephalic or brachio-basilic fistulas (69%). Women
were noted to have a brachial artery origin more frequently than men (OR
3.1, p0.009) in current practice. Forty-four mild cases were observed
uneventfully. Results of 87 interventions on 70 patients are in Table I. Of
these, 31 early procedures (30 days from index fistula) weremostly ligation
(42%) or banding (45%) while Distal Revascularization, Interval Ligation
(DRIL) was the most frequent choice for late interventions (38%). DRIL
had a better success rate than banding (p  0.05). Of the 11 patients
requiring repeat intervention, the majority had failed banding procedures
(73%). In our current practice, 18% of patients had an AV fistula with the
proximal radial artery (PRA) as the inflow source, while this type of fistula
accounted for only 2% of all IS patients. Ligation resolved symptoms in all
patients, but the AV access was lost.
Conclusions: Among various options to treat IS, banding has a low
success rate and high likelihood for re-intervention, while DRIL is particu-
larly effective, though not uniformly. Women have more IS probably be-
cause they frequently have more proximal access. Use of the PRA as the
inflow source may decrease the incidence of IS.
Success of management techniques
Management technique N Follow-up Success (95% CI)
Ligation 27 25 0% (NA)
Banding 22 21 38% (17% - 59%)
DRIL 21 20 80% (62% - 98%)*
Improve inflow 9 7 43% (NA)
Revision using distal
inflow (RUDI)
4 3 100% (NA)
Proximalization of arterial
inflow (PAI)
3 3 100% (NA)
Distal revascularization 1 1 100% (NA)*Statistically significant at p0.05.Author Disclosures: N. Gupta, None; T.H. Yuo, None; G. Konig,
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Predicted Shortage of Vascular Surgeons in the United States: Popu-
lation and Workload Analysis.
Bhagwan Satiani, Thomas E Williams, Michael R Go. The Ohio State
University, Columbus, OH
Objective: To estimate the size of the future workforce in Vascular
Surgery (VS) and the added cost associated with addressing the projected
shortage in the United States.
Methods: The net supply (number of VS currently practicing, new
graduates entering the workforce and those retiring) for each decade was
calculated. The projected population for each decade was determined by US
Census Bureau figures. Some of the assumptions included: (1) In 2008 the
population was 300,000,000; 2) There were 2783 board certified VS in
2008; (3) VS will practice 30 years from board certification to retirement;
(4) there will be 105 board certifications and 93 retirements a year; (5)
Vascular operations will remain at 284 per 100,000 population and (6)
Salaries of trainees will be $50,000 with benefits of 30%, and $ 15,000 of
additional DME costs.
Results:
Population Analysis:
Year
Projected
population
Vascular
surgeons
needed
Vascular
surgeons
in practice Shortage % Shortage
2000 282,000,000
2010 309,000,000 2,866 2,807 59 2.1%
2020 336,000,000 3,117 2,927 190 6.1%
2030 364,000,000 3,377 3,047 330 9.8%
2040 392,000,000 3,636 3,150 486 13.4%
2050 420,000,000 3,896 3,150 746 19.2%
Workload Analysis
Year
Projected
population
Estimated
work load for
population
Vascular
surgeons
needed
Vascular
surgeons
in practice Shortage
Percent
shortage
2000 282,000,000
2010 309,000,000 877,560 4,112 2,807 1,305 31.7%
2020 336,000,000 954,240 4,472 2,927 1,545 34.5%
2030 364,000,000 1,033,760 4,844 3,047 1,797 37.1%
2040 392,000,000 1,113,280 5,217 3,150 2,067 39.6%
2050 420,000,000 1,192,800 5,590 3,150 2,440 43.6%
Conclusions: A conservative estimate by both population and work-
load analysis, disregarding ageing of the population, lifestyle choices of
future VS and increasing demand for services, indicates a shortage of VS in
the future. The cost of training enough VS surgeons by 2030 will be
between $1,166,400,000 and $2,182,320,000.Unless the Balanced Budget
Act of 1997 is revised by Congress, the cost to train the additional VS
remains a significant barrier.
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Midterm Postoperative Surveillance of EVAR and Endoleak Prediction
Using SAC Pressure and Volume Monitoring
Feng Qin1, Rajeev Dayal1, Justin Rafael1, Luis Davila-Santini1, Julio Cal-
derin1, Lorena DeMarco-Garcia1, Nicole Johnson2, Richard Schultzer1,
Mihai Rosca1,Mark Kissin1, John Chang1, Omid Rahmani1, Toufic K Safa1,
William Purtill1, Mark Gennarro1, Kambhampaty Krishnasastry1. 1North
Shore-LIJ Healthcare System, Lake success, NY; 2Albert Einstein College of
Medicine, Bronx, NYObjective: To evaluate the utility of aneurysm sac pressure and aneu-
rysm volume monitoring for EVAR surveillance.
